Studies of liver cancer 34, colon cancer 35, and thyroid cancer 36 have shown that SMOC2 can regulate malignant tumor progression, can serve as a tumor stem cell marker, and is closely related to patient prognosis. This evidence concerns the gene SMOC2 and colonic neoplasm.